In Stock
Selegiline is a Monoamine Oxidase-B (MAO-B) inhibitor used for the treatment of Parkinson’s disease and major depressive disorder. It helps increase levels of dopamine in the brain, improving movement control, coordination, and overall mood. Often used alone or along with Levodopa or Carbidopa, it enhances motor function and reduces symptoms like stiffness, tremor, and slowness of movement.
Selegiline – The active pharmaceutical ingredient. It is a monoamine oxidase-B (MAO-B) inhibitor that helps reduce the breakdown of dopamine in the brain, thereby increasing its availability and activity.
Pharmaceutical Excipients – Inactive ingredients used to maintain the medicine's stability, quality, formulation, and proper drug delivery.
Selegiline is a prescription medicine used primarily in the management of Parkinson’s disease and, in specific formulations, certain depressive disorders. It should be used only under the guidance of a qualified healthcare professional.
Selegiline can interact with various medicines and, depending on the formulation and dosage, may require specific dietary or medication precautions. Do not self-medicate, change the dosage, or discontinue treatment without medical advice.
Individual response to treatment may vary depending on the patient's medical condition, prescribed formulation, dosage, and other factors. Always follow your healthcare professional's instructions regarding dosage, duration, medication interactions, and monitoring.